Invention Grant
- Patent Title: Cancer antigen helper peptide
-
Application No.: US15831484Application Date: 2017-12-05
-
Publication No.: US10759840B2Publication Date: 2020-09-01
- Inventor: Haruo Sugiyama
- Applicant: International Institute Of Cancer Immunology, Inc.
- Applicant Address: JP Osaka
- Assignee: International Institute of Cancer Immunology, Inc.
- Current Assignee: International Institute of Cancer Immunology, Inc.
- Current Assignee Address: JP Osaka
- Agency: Finnegan, Henderson, Farabow, Garrett & Dunner, L.L.P.
- Priority: com.zzzhc.datahub.patent.etl.us.BibliographicData$PriorityClaim@3d4612b3
- Main IPC: A61K38/00
- IPC: A61K38/00 ; C07K14/47 ; A61K39/00 ; G01N33/574 ; C07K16/18 ; C07K16/30 ; C12N5/078 ; G01N33/569
Abstract:
The present invention relates to a WT1 peptide which has an amino acid sequence consisting of contiguous amino acids derived from a WT1 protein and induces WT1-specific helper T cells by binding to an MHC class II molecule, a pharmaceutical composition comprising them and the like.
Public/Granted literature
- US20180170986A1 CANCER ANTIGEN HELPER PEPTIDE Public/Granted day:2018-06-21
Information query
IPC分类:
